These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8484123)

  • 21. Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.
    Deb DK; Srivastava KK; Srivastava R; Srivastava BS
    Biochem Biophys Res Commun; 2000 Dec; 279(2):457-61. PubMed ID: 11118308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase.
    Cooksey RC; Crawford JT; Jacobs WR; Shinnick TM
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1348-52. PubMed ID: 8328785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.
    Hickey MJ; Arain TM; Shawar RM; Humble DJ; Langhorne MH; Morgenroth JN; Stover CK
    Antimicrob Agents Chemother; 1996 Feb; 40(2):400-7. PubMed ID: 8834887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.
    Zhang Y; Dhandayuthapani S; Deretic V
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13212-6. PubMed ID: 8917570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis.
    da Silva PA; Boffo MM; de Mattos IG; Silva AB; Palomino JC; Martin A; Takiff HE
    Clin Microbiol Infect; 2006 Mar; 12(3):293-6. PubMed ID: 16451420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viability.
    Larsson MC; Lerm M; Ängeby K; Nordvall M; Juréen P; Schön T
    J Microbiol Methods; 2014 Nov; 106():146-150. PubMed ID: 25194234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery.
    Arain TM; Resconi AE; Hickey MJ; Stover CK
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1536-41. PubMed ID: 8726034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of a nucleic acid-based reporter system to detect Mycobacterium tuberculosis antibiotic sensitivity.
    Mulvey MC; Lemmon M; Rotter S; Lees J; Einck L; Nacy CA
    Antimicrob Agents Chemother; 2015 Jan; 59(1):407-13. PubMed ID: 25367910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance.
    Galí N; Domínguez J; Blanco S; Prat C; Alcaide F; Coll P; Ausina V
    J Clin Microbiol; 2006 Jan; 44(1):201-5. PubMed ID: 16390970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.
    Djemal SE; Camperio C; Armas F; Siala M; Smaoui S; Messadi-Akrout F; Gdoura R; Marianelli C
    BMC Vet Res; 2018 Sep; 14(1):296. PubMed ID: 30268120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and evaluation of luciferase reporter phages for the detection of active and non-replicating tubercle bacilli.
    Dusthackeer A; Kumar V; Subbian S; Sivaramakrishnan G; Zhu G; Subramanyam B; Hassan S; Nagamaiah S; Chan J; Paranji Rama N
    J Microbiol Methods; 2008 Apr; 73(1):18-25. PubMed ID: 18272245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system.
    Telles MA; Bori A; Amorim AB; Cruz AF; Pini MI; Sato DN
    Braz J Med Biol Res; 2002 Oct; 35(10):1127-31. PubMed ID: 12424483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria.
    Soetaert K; Rens C; Wang XM; De Bruyn J; Lanéelle MA; Laval F; Lemassu A; Daffé M; Bifani P; Fontaine V; Lefèvre P
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5057-60. PubMed ID: 26033733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoromycobacteriophages for Drug Susceptibility Testing (DST) of Mycobacteria.
    Piuri M; Hatfull GF
    Methods Mol Biol; 2019; 1898():27-36. PubMed ID: 30570720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reliability of bioluminescent assay (ATP method) for testing antimicrobial susceptibility of Mycobacterium tuberculosis].
    Yamazaki T; Sato N; Yamashita K; Okazawa Y; Araki H; Miwa A
    Rinsho Byori; 2003 Mar; 51(3):194-200. PubMed ID: 12707990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host range of 14 mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria including Mycobacterium tuberculosis--application for identification and susceptibility testing.
    Rybniker J; Kramme S; Small PL
    J Med Microbiol; 2006 Jan; 55(Pt 1):37-42. PubMed ID: 16388028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.